These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27167507)

  • 61. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial.
    Brixner V; Bug G; Pohler P; Krämer D; Metzner B; Voss A; Casper J; Ritter U; Klein S; Alakel N; Peceny R; Derigs HG; Stegelmann F; Wolf M; Schrezenmeier H; Thiele T; Seifried E; Kapels HH; Döscher A; Petershofen EK; Müller TH; Seltsam A
    Haematologica; 2021 Apr; 106(4):1086-1096. PubMed ID: 33538149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
    Singh S; Shams Hakimi C; Jeppsson A; Hesse C
    Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
    Prudent M; D'Alessandro A; Cazenave JP; Devine DV; Gachet C; Greinacher A; Lion N; Schubert P; Steil L; Thiele T; Tissot JD; Völker U; Zolla L
    Transfus Med Rev; 2014 Apr; 28(2):72-83. PubMed ID: 24685438
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction.
    Tauszig ME; Picker SM; Gathof BS
    Transfus Apher Sci; 2012 Feb; 46(1):33-7. PubMed ID: 22119364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols.
    Arbaeen AF; Schubert P; Serrano K; Carter CJ; Culibrk B; Devine DV
    Transfusion; 2017 May; 57(5):1208-1217. PubMed ID: 28236302
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion.
    Zhi L; Chi X; Vostal JG
    PLoS One; 2013; 8(11):e79869. PubMed ID: 24224014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
    Lozano M; Galan A; Mazzara R; Corash L; Escolar G
    Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Small volume platelet concentrates for neonatal use are more susceptible to shear-induced storage lesion.
    Pym D; Davies AJ; Williams JO; Saunders C; George CE; James PE
    Platelets; 2024 Dec; 35(1):2389967. PubMed ID: 39169763
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.
    Viau S; Chabrand L; Eap S; Lorant J; Rouger K; Goudaliez F; Sumian C; Delorme B
    PLoS One; 2017; 12(8):e0181406. PubMed ID: 28763452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma.
    Kwon SY; Kim IS; Bae JE; Kang JW; Cho YJ; Cho NS; Lee SW
    Vox Sang; 2014 Oct; 107(3):254-60. PubMed ID: 24806328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
    Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
    Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
    Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
    Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system.
    van der Meer PF; Kerkhoffs JL; Curvers J; Scharenberg J; de Korte D; Brand A; de Wildt-Eggen J
    Vox Sang; 2010 May; 98(4):517-24. PubMed ID: 19930144
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of interruption of agitation on in vitro measures of platelet concentrates in additive solution.
    van der Meer PF; Liefting LA; Pietersz RN
    Transfusion; 2007 Jun; 47(6):955-9. PubMed ID: 17524082
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates.
    Middelburg RA; Roest M; Ham J; Coccoris M; Zwaginga JJ; van der Meer PF
    Transfusion; 2013 Aug; 53(8):1780-7. PubMed ID: 23216254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.